When we talk about clinical trials, most conversations focus on recruiting participants. During my pharmacy studies, I also believed that once enough volunteers were enrolled, the difficult part was over. But as I explored clinical research further, I realized that keeping participants engaged until the study ends can be even more challenging than recruiting them.
A clinical trial may begin with the required number of participants, but if many of them discontinue the study midway, it can affect the quality and reliability of the results. Every participant who withdraws means there is less data available to answer the research question, and in some cases, the entire study timeline may be affected.
It made me wonder why participants choose to leave a study. The reasons are often more practical than we imagine. Some participants may have to travel long distances for follow-up visits. Others may find frequent hospital visits difficult to manage alongside work or family responsibilities. Some may experience side effects, lose interest, or simply feel overwhelmed by the study schedule.
This reminded me that clinical research is not just about protocols and data collection, it is also about understanding people. Participants are not just study numbers; they are individuals who volunteer their time and place their trust in the research team. Making them feel informed, respected, and supported throughout the study is just as important as following the protocol.
I believe good communication plays a major role in patient retention. When participants clearly understand the purpose of the study, know what to expect, and feel comfortable asking questions, they are more likely to stay involved. Small efforts such as timely follow-ups, clear explanations, and empathy can make a meaningful difference to their overall experience.
As future professionals interested in clinical research, we often focus on scientific knowledge and regulations. While these are essential, building trust with participants is equally important. A well-designed study cannot achieve its objective if participants are unable or unwilling to complete it.
Clinical research succeeds because people choose to participate. Retaining those participants is not just about meeting study targets, it is about respecting their contribution and ensuring that the evidence generated is as complete and reliable as possible.
In your opinion, what can research teams do to improve patient retention in clinical trials? I’d love to hear your ideas and experiences in the comments.
MBH/PS